Acute glycaemic effects of co-trimoxazole at prophylactic dose in healthy adults
暂无分享，去创建一个
[1] P. Cryer,et al. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. , 1987, The Journal of clinical investigation.
[2] Z. Hekimsoy,et al. Trimethoprim/sulfamethoxazole-induced hypoglycemia in a malnourished patient with severe infection. , 1997, European journal of endocrinology.
[3] R. Quick,et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda , 2004, The Lancet.
[4] S. Hennessy,et al. Anti‐Infectives and the Risk of Severe Hypoglycemia in Users of Glipizide or Glyburide , 2010, Clinical pharmacology and therapeutics.
[5] A. Garber,et al. Sulfonamide-induced hypoglycemia in chronic renal failure. , 1983, Archives of internal medicine.
[6] D. Juurlink,et al. Considerations when prescribing trimethoprim–sulfamethoxazole , 2011, Canadian Medical Association Journal.
[7] G. Nunnari,et al. Trimethoprim-sulfamethoxazole-associated severe hypoglycaemia: a sulfonylurea-like effect. , 2010, European review for medical and pharmacological sciences.
[8] A. Kuper,et al. Severe and protracted hypoglycaemia associated with co-trimoxazole use. , 2006, The Lancet. Infectious diseases.
[9] Z. Dou,et al. Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China , 2015, Bulletin of the World Health Organization.